F. Canedo

Bevacizumab-associated osteonecrosis of the femur and tibia

A. Shimada, A. Katz, J. Alessi, 2019, Oxford medical case reports.

Expanding the phenotype of E318K (c.952G > A) MITF germline mutation carriers: case series and review of the literature

M. Achatz, B. Rossi, J. Pisani, 2021, Hereditary cancer in clinical practice.

Tumor Lysis Syndrome After Platinum‐based Chemotherapy in Castration‐resistant Prostate Cancer With a BRCA2 Mutation: A Case Report

A. Camargo, D. Bastos, P. Asprino, 2019, Clinical genitourinary cancer.

Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient

A. Camargo, A. Shimada, F. Bettoni, 2021, npj Precision Oncology.

Successful osimertinib rechallenge following drug-induced pneumonitis after previous anti-PDL1 exposure

G. de Castro, F. Santini, G. Harada, 2019, Ecancermedicalscience.

Complete response to alectinib following crizotinib in an ALK-positive inflammatory myofibroblastic tumor with CNS involvement

Luiz Guilherme Cernaglia Aureliano Lima, O. Feher, J. Marin, 2021, Current Problems in Cancer: Case Reports.